Connecticut SB 138: AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

Status: FILED WITH LCO (as of 2020-03-11)

State: Connecticut · Session: 2020 · Bill: SB 138

Subjects: Drugs, Unfair or deceptive trade practices, Pharmaceutical manufacturing companies

Sponsors: Anwar, Saud, Looney, Martin M.

View Connecticut SB 138 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.